Working... Menu

Secukinumab Efficacy Without the Initial Loading Dose in Patients With Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03828643
Recruitment Status : Completed
First Posted : February 4, 2019
Last Update Posted : April 16, 2019
Information provided by (Responsible Party):
Paolo Gisondi, Universita di Verona

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 12, 2019
  Actual Study Completion Date : April 12, 2019